Edie24m
Pharma giants support Chinese suppliers to source renewable power
Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...
New rule for GST registration: Now biometric authentication in your home state is possible when you do GST registration in another state
Now biometric authentication in your home state is possible when you do GST registration in another state, GSTN Advisory on ...
Gender pay gap improves but only one in five businesses have eliminated it
New data shows Australia's gender pay gap has narrowed, but working women are still more than $28,000 a year worse off than ...
National Cancer Survivors Day Foundation Publishes Comprehensive Listing Of Cancer-Related Public Speakers
The NCSD Speakers Bureau Roster features nearly 250 public speakers, celebrities, cancer survivors, and medical professionals eligible to ...
ENDPOINTS NEWS3h
ICER finds GSK in­halers of­fer ad­van­tages over gener­ic com­peti­tors
The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations ...
GSK announces U.S. FDA accepted for review BLA for depemokimab
GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review the Biologics License Application, BLA, for the use of ...
GSK reports positive outcomes from two Phase III trials of treatment for CRSwNP
Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.
bizenglish.adaderana6h
Haleon partners Sri Lanka Dental Association as Official Sponsor for World Oral Health Day 2025
Haleon Sri Lanka formerly known as GlaxoSmithKline Healthcare; the first multinational pharmaceutical manufacturing organization in Sri Lanka, which commenced manufacturing in 1956 with the flagship ...
EconoTimes7h
FDA Reviews GSK’s Depemokimab for Asthma and CRSwNP Treatment
The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for ...
FDA to review GSK's depemokimab
Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License ...
Buy7h
LONDON MARKET OPEN: Stocks rise, Hunting pleases with Rival sale
(Alliance News) - Stock prices in London opened higher on Monday, ahead of the UK manufacturing PMI and following like releases from other regions. The FTSE 100 index opened up 34.18 points, 0.4%, at ...
GSK says US FDA accepts two depemokimab indication submissions
(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has accepted for review the biologics license application for depemokimab in two indications - for asthma with type 2 ...